ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 1.61 USD -1.23%
Market Cap: 71.5m USD
Have any thoughts about
ESSA Pharma Inc?
Write Note

ESSA Pharma Inc
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ESSA Pharma Inc
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
ESSA Pharma Inc
NASDAQ:EPIX
Other Current Assets
$636.5k
CAGR 3-Years
-34%
CAGR 5-Years
1%
CAGR 10-Years
20%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Other Current Assets
CA$168.2k
CAGR 3-Years
29%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Other Current Assets
$1.7m
CAGR 3-Years
-32%
CAGR 5-Years
-8%
CAGR 10-Years
7%
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Other Current Assets
$17m
CAGR 3-Years
8%
CAGR 5-Years
36%
CAGR 10-Years
27%
Covalon Technologies Ltd
XTSX:COV
Other Current Assets
CA$765.4k
CAGR 3-Years
-4%
CAGR 5-Years
11%
CAGR 10-Years
24%
Spectral Medical Inc
TSX:EDT
Other Current Assets
CA$882k
CAGR 3-Years
4%
CAGR 5-Years
26%
CAGR 10-Years
9%
No Stocks Found

ESSA Pharma Inc
Glance View

Market Cap
71.5m USD
Industry
Biotechnology

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 30 full-time employees. The firm is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The firm is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.

EPIX Intrinsic Value
8.8 USD
Undervaluation 82%
Intrinsic Value
Price

See Also

What is ESSA Pharma Inc's Other Current Assets?
Other Current Assets
636.5k USD

Based on the financial report for Sep 30, 2024, ESSA Pharma Inc's Other Current Assets amounts to 636.5k USD.

What is ESSA Pharma Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
20%

Over the last year, the Other Current Assets growth was 9%. The average annual Other Current Assets growth rates for ESSA Pharma Inc have been -34% over the past three years , 1% over the past five years , and 20% over the past ten years .

Back to Top